Edition:
United States

Aevi Genomic Medicine Inc (GNMX.OQ)

GNMX.OQ on NASDAQ Stock Exchange Global Market

1.67USD
22 May 2018
Change (% chg)

$-0.03 (-1.76%)
Prev Close
$1.70
Open
$1.67
Day's High
$1.67
Day's Low
$1.67
Volume
2,253
Avg. Vol
33,393
52-wk High
$2.64
52-wk Low
$0.98

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Mar '18 0.00 -0.147
FY 2017 Dec '17 0.00 -0.129
Sep '17 0.00 -0.232
Jun '17 0.00 -0.216
Mar '17 0.00 -0.294
FY 2016 Dec '16 0.00 -0.229
Sep '16 0.00 -0.285
Jun '16 0.00 -0.350
Mar '16 0.00 -0.338
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Jun-18 2 0.00 0.00 0.00 0.00
Quarter Ending Sep-18 2 0.00 0.00 0.00 0.00
Year Ending Dec-18 3 0.00 0.00 0.00 0.00
Year Ending Dec-19 2 0.00 0.00 0.00 0.00
Earnings (per share)
Quarter Ending Jun-18 3 -0.15 -0.15 -0.16 -0.35
Quarter Ending Sep-18 3 -0.16 -0.14 -0.17 -0.37
Year Ending Dec-18 3 -0.61 -0.58 -0.65 -1.43
Year Ending Dec-19 3 -0.93 -0.61 -1.27 -1.82
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 222.84 32.59
P/E High - Last 5 Yrs. -- 281.48 47.07
P/E Low - Last 5 Yrs. -- 95.47 24.59
Beta 1.16 0.75 0.79
Price to Sales (TTM) -- 262.06 9.01
Price to Book (MRQ) 4.44 23.14 4.24
Price to Tangible Book (MRQ) 4.34 26.27 5.79
Price to Cash Flow (TTM) -- 127.68 21.78
% Owned Institutions 23.07 10.94 2.43

Dividends

  Company industry sector
Dividend Yield -- 0.30 1.66
Dividend Yield - 5 Year Avg -- 0.21 0.80
Dividend 5 Year Growth Rate -- 2.35 4.15
Payout Ratio(TTM) -- 46.91 17.73

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 26.86 5.10
Sales (TTM) vs TTM 1 Yr. Ago -- 150.04 12.65
Sales - 5 Yr. Growth Rate -- 30.10 8.10
EPS (MRQ) vs Qtr. 1 Yr. Ago 50.11 -158.81 33.25
EPS (TTM) vs TTM 1 Yr. Ago 37.42 -- --
EPS - 5 Yr. Growth Rate -- 46.66 8.54
Capital Spending - 5 Yr. Growth Rate -42.38 38.70 8.77

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.64 2.50
Current Ratio (MRQ) 5.77 6.54 3.56
LT Debt to Equity (MRQ) 0.00 22.23 12.86
Total Debt to Equity (MRQ) 0.00 25.74 15.83
Interest Coverage (TTM) -- -177.44 35.15

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 33.95 54.64
Gross Margin - 5 Yr. Avg. -- 54.86 52.74
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -158.47 15.84
Operating Margin (TTM) -- -930.08 -2.34
Operating Margin - 5 Yr. Avg. -- -171.29 11.09
Pre-Tax Margin (TTM) -- -814.97 -0.23
Pre-Tax Margin - 5 Yr. Avg. -- -176.85 11.29
Net Profit Margin (TTM) -- -806.24 -3.64
Net Profit Margin - 5 Yr. Avg. -- -176.13 7.58
Effective Tax Rate (TTM) -- 14.58 31.25
Effective Tax Rate - 5 Yr. Avg. -- 18.23 24.61

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 21,442,083 721,262,098
Net Income/Employee (TTM) -1,912,118 -1,504,037 83,813,821
Receivable Turnover (TTM) -- 16.37 5.67
Inventory Turnover (TTM) -- 2.46 3.55
Asset Turnover (TTM) 0.00 0.42 0.85

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -112.16 -5.46 9.98
Return on Assets - 5 Yr. Avg. -86.59 -0.52 11.07
Return on Investment (TTM) -136.07 -7.75 12.60
Return on Investment - 5 Yr. Avg. -97.49 2.72 14.34
Return on Equity (TTM) -136.07 -10.55 14.49
Return on Equity - 5 Yr. Avg. -100.32 -2.70 15.71
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % 30.11 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Aevi Genomic Medicine Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 23.07%
# of Holders: 55
Total Shares Held: 13,689,352
3 Mo. Net Change: 1,422,731
# New Positions: 6
# Closed Positions: 9
# Increased Positions: 11
# Reduced Positions: 22
# Net Buyers: -11
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.